Chapel Hill, N.C.
Went public 10/11/00 at $15 per share
Filing Range:5.0 million shares @ $14 to $16
Shares Outstanding:26.4 million shares
Underwriters: U.S. Bancorp Piper Jaffray/Prudential Vector Healthcare/Pacific Growth Equities Inc.
Company Counsel: Morgan Lewis & Bockius
Manager Counsel: Ballard Spahr Andrews & Ingersoll
Auditor: Ernst & Young LLP
Operates a pharmaceutical development company. Pozen’s initial area of focus is migraines, where it has built a portfolio of four product candidates through a combination of innovation and in-licensing.
Vector Fund Management LP
Number of Round Amt.
Round # Round Date Stage Investors ($ thousands)
1 12/01/1996 1 Early Stage 6634.0
2 12/01/1997 1 Early Stage 4540.0
3 03/01/1998 1 Expansion 2300.0
4 07/01/1999 2 Later Stage 12450.0
5 08/01/2000 4 Later Stage 29101.0
(Data in $ millions)
Total Revenues: $0.0
Net Income: -11.3